BioRestorative Therapies, Inc. (BRTX) vs Jaguar Health, Inc. (JAGX)
A side-by-side comparison of BioRestorative Therapies, Inc. and Jaguar Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BRTX
BioRestorative Therapies, Inc.
$2.18HealthcareDelayed quote: Oct 6, 2026, 1:12 PM EDT
JAGX
Jaguar Health, Inc.
$5.76HealthcareDelayed quote: Oct 6, 2026, 1:20 PM EDT
Total return — BRTX vs JAGX
growth of $100 · dividends reinvested · last 10yBRTX -100.0% (-62.5%/yr)JAGX -100.0% (-84.1%/yr)BRTX compounded faster over this window
Log scale — wide-divergence pair
BRTX JAGX
BRTX vs JAGX: by the numbers
- •BRTX is the larger company ($3M vs $2M market cap).
- •Both run net losses; JAGX's is the smaller (-131.76% vs -3089.55% net margin).
- •BRTX grew revenue faster over the past five years (38.99% vs 31.88% CAGR).
Metrics side by side
Valuation
| Metric | BRTX | JAGX |
|---|---|---|
| P/S ratio | 8.41 | 0.09 |
| P/B ratio | 1.00 | 0.38 |
Profitability
| Metric | BRTX | JAGX |
|---|---|---|
| Gross margin | 92.09% | 67.21% |
| Operating margin | -4350.05% | -391.87% |
| Net margin | -3089.55% | -131.76% |
| ROE | -365.43% | -554.01% |
| ROIC | -464.86% | -110.81% |
Growth (annualized)
| Metric | BRTX | JAGX |
|---|---|---|
| Revenue CAGR (5Y) | 38.99% | 31.88% |
| Total return CAGR (5Y) | -61.44% | N/A |
Frequently asked
- Which has grown faster, BRTX or JAGX?
- Over the past five years, BRTX grew revenue faster — BRTX at a 38.99% CAGR versus JAGX at 31.88%.
Go deeper
Dig into the metrics
BioRestorative Therapies ROEJaguar Health ROEBioRestorative Therapies operating marginJaguar Health operating marginBioRestorative Therapies revenue growthJaguar Health revenue growthBioRestorative Therapies free cash flowJaguar Health free cash flow
BioRestorative Therapies & Jaguar Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.